Catalyst Wire Dossier Catalyst Wire Dossier

A2NTX

botulinum toxin type A2NTX
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A2NTX, covering 2014-01-10 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke [Phase 2, Phase 3]

See pricing